Amgen Inc. (AMG.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 12:30PM CEST
| Previous Close | 288.40 |
| Open | 288.30 |
| Bid | 286.50 x 30000 |
| Ask | 287.90 x 30000 |
| Day's Range | 288.25 - 293.00 |
| 52 Week Range | 199.20 - 304.00 |
| Volume | |
| Avg. Volume | 210 |
| Market Cap | 155.593B |
| Beta (5Y Monthly) | 0.60 |
| PE Ratio (TTM) | 45.04 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 8.28 (2.86%) |
| Ex-Dividend Date | May 16, 2024 |
| 1y Target Est | N/A |
- Zacks
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Amgen's (AMGN) Imdelltra is the first DLL3-targeting BiTE therapy that activates the patient's own T cells to attack DLL3-expressing tumor cells.
- Zacks
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this space.
- Zacks
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
© 2024 Yahoo. All rights reserved.